Abstract
Purpose
Infective endocarditis (IE) remains a prevalent and life-threatening disease. The choice to repair or replace the infected valve still remains a matter of debate, especially in aortic valve (AV) infections. We retrospectively analyze our two decades of experience in aortic valve repair (AVr) in IE. Long-term outcomes are described with particular attention to the impact of valve configuration and the use of patch techniques.
Methods
From September 1998 to June 2017, 42 patients underwent AVr in a single center for IE. Techniques include leaflet patch repair and resuspension and aortic annulus stabilization.
Results
Hospital mortality was 2.4% (n = 1). The median follow-up was 90.6 months. Survival was 89 ± 9.4% and 76.6 ± 16% at 5 and 10 years, respectively, with no significant differences between tricuspid aortic valve (TAV) and bicuspid aortic valve (BAV). Freedom from reoperation was 100% and 92.9 ± 7.1% in TAV and 81.8 ± 18.2% and 46.8 ± 28.8% in BAV at 5 and 10 years, respectively (TAV vs BAV, p = 0.02). BAV, degree of preoperative aortic insufficiency, and AVr including patch were factors predicting a higher risk of reoperation during the follow-up.
Conclusion
In our experience, AVr is a safe, feasible, and efficient choice in selected patients with healed or active IE. Durability of the repair is excellent in patients with limited lesions and in patients with TAV even with patch repair. Reoperations occurred principally in patients with BAV and severe preoperative AI, in whom patch repair was performed. In those patients, we actually recommend to replace the valve in case of active endocarditis.
Similar content being viewed by others
References
Aicher D, Fries R, Rodionycheva S, Schmidt K, Langer F, Schäfers HJ. Aortic valve repair leads to a low incidence of valve-related complications. Eur J Cardiothoracic Surg. 2010;37:127–132.
Price J, De Kerchove L, Glineur D, Vanoverschelde JL, Noirhomme P, El Khoury G. Risk of valve-related events after aortic valve repair. Ann Thorac Surg. 2013;95:606–612.
Lansac E, Di Centa I, Sleilaty G, et al. Long-term results of external aortic ring annuloplasty for aortic valve repair. Eur J Cardiothoracic Surg. 2016;50:350–360.
Nezhad ZM, De Kerchove L, Hechadi J, et al. Aortic valve repair with patch in non-rheumatic disease: Indication, techniques and durability. Eur J Cardiothoracic Surg. 2014;46:997–1005.
Schneider U, Feldner SK, Hofmann C, et al. Two decades of experience with root remodeling and valve repair for bicuspid aortic valves. J Thorac Cardiovasc Surg. 2017;153:S65–S71.
Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–638.
Chu VH, Sexton DJ, Cabell CH, et al. Repeat infective endocarditis: differentiating relapse from reinfection. Clin Infect Dis. 2005;41:406–409.
Bell D, Prabhu S, Betts K, et al. Durability of tissue-engineered bovine pericardium (CardioCel®) for a minimum of 24 months when used for the repair of congenital heart defects. Interact Cardiovasc Thorac Surg. 2019;28:284–290.
Tamer S, de Kerchove L, Glineur D, El Khoury G. Video-atlas of aortic valve repair. Ann Cardiothorac Surg. 2013;2:124–126.
Boodhwani M, de Kerchove L, Glineur D, et al. Repair-oriented classification of aortic insufficiency: Impact on surgical techniques and clinical outcomes. J Thorac Cardiovasc Surg. 2009;137:286–294.
Boodhwani M, De Kerchove L, Glineur D, et al. Repair of regurgitant bicuspid aortic valves: A systematic approach. J Thorac Cardiovasc Surg. 2010;140:276–284.
Van Dyck M, Glineur D, de Kerchove L, El Khoury G. Complications after aortic valve repair and valve-sparing procedures. Ann Cardiothorac Surg. 2013;2:130–139.
Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the Management of Infective Endocarditis. Eur Heart J.2015;36:3075–3128.
Akins CW, Miller DC, Turina MI, et al. Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg. 2008;135:732–738.
Van Den Brink FS, Swaans MJ, Hoogendijk MG, et al. Increased incidence of infective endocarditis after the 2009 European Society of Cardiology guideline update: A nationwide study in the Netherlands. Eur Hear J Qual Care Clin Outcomes. 2017;3:141–147.
Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015;36:3075–3128.
Leone S, Ravasio V, Durante-Mangoni E, et al. Epidemiology, characteristics, and outcome of infective endocarditis in Italy: The Italian Study on Endocarditis. Infection. 2012;40:527–535.
García-Cabrera E, Fernández-Hidalgo N, Almirante B, et al. Neurological complications of infective endocarditis risk factors, outcome, and impact of cardiac surgery: A multicenter observational study. Circulation. 2013;127:2272–2284.
Botelho-Nevers E, Thuny F, Casalta JP, et al. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Intern Med. 2009;169:1290–1298. https://doi.org/10.1001/archinternmed.2009.192.
David TE, Gavra G, Feindel CM, Regesta T, Armstrong S, Maganti MD. Surgical treatment of active infective endocarditis: A continued challenge. J Thorac Cardiovasc Surg. 2007;133:144–149.
Savage EB, Saha-Chaudhuri P, Asher CR, Brennan JM, Gammie JS. Outcomes and prosthesis choice for active aortic valve infective endocarditis: analysis of the society of thoracic surgeons adult cardiac surgery database. Ann Thorac Surg. 2014;98:806–814.
Klieverik LM, Yacoub MH, Edwards S, et al. Surgical treatment of active native aortic valve endocarditis with allografts and mechanical prostheses. Ann Thorac Surg. 2009;88:1814–1821.
Moon MR, Miller DC, Moore KA, et al. Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis. Ann Thorac Surg. 2001;71:1164–1171.
Mayer K, Aicher D, Feldner S, Kunihara T, Schäfers HJ. Repair versus replacement of the aortic valve in active infective endocarditis. Eur J Cardiothorac Surg. 2012;42:122–127.
Zhao D, Zhang B. Are valve repairs associated with better outcomes than replacements in patients with native active valve endocarditis? Interact Cardiovasc Thorac Surg. 2014;19:1036–1039.
De Kerchove L, Boodhwani M, Glineur D, et al. Valve sparing-root replacement with the reimplantation technique to increase the durability of bicuspid aortic valve repair. J Thorac Cardiovasc Surg. 2011;142:1430–1438.
Acknowledgments
The authors thank Corinne Coulon for her outstanding work as data manager.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study
Conflict of interest
The authors declare that they have no conflict of interest.
Funding
Nil
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Solari, S., Tamer, S., Aphram, G. et al. Aortic valve repair in endocarditis: scope and results. Indian J Thorac Cardiovasc Surg 36 (Suppl 1), 104–112 (2020). https://doi.org/10.1007/s12055-019-00831-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12055-019-00831-0